Core Concept - The Liver's Tollbooth
- Orally administered drugs are absorbed from the GI tract and travel first to the liver via the portal vein before reaching systemic circulation.
- The liver metabolizes a fraction of the drug, reducing its active concentration. This is the First-Pass Effect.
- This process significantly lowers a drug's bioavailability (F).
- Drugs with high first-pass metabolism (e.g., lidocaine, morphine, propranolol) require much larger oral doses than parenteral doses.
⭐ High first-pass metabolism is why drugs like nitroglycerin are given sublingually-bypassing the liver for rapid, direct systemic absorption and higher bioavailability.

Clinical Significance - Dose & Route Roulette
- First-Pass Effect: Orally administered drugs are absorbed from the GI tract and enter portal circulation, passing through the liver before reaching systemic circulation. The liver metabolizes a portion of the drug, reducing its concentration.
- Bioavailability (F): The fraction of administered drug that reaches systemic circulation unchanged. For oral drugs, it's reduced by the first-pass effect.
- Calculated as: $F = f \times (1 - ER)$, where ER is the hepatic extraction ratio.

-
Dose Discrepancy: Drugs with high first-pass metabolism have a much larger oral dose than parenteral dose to achieve equivalent therapeutic effect.
- Examples: Lidocaine, Morphine, Propranolol, Nitroglycerin.
-
Bypassing the Liver: Alternative routes avoid the portal vein and thus, first-pass metabolism.
- Routes: IV, IM, Subcutaneous, Sublingual (SL), Transdermal, Inhalational, and a portion of Rectal (PR) administration.
⭐ Exam Favorite: Nitroglycerin has nearly 100% first-pass metabolism, making oral administration ineffective. It is given sublingually or transdermally for rapid absorption directly into systemic circulation, bypassing the liver for acute angina treatment.
Influencing Factors - The Metabolic Modulators
-
Enzyme Inducers: ↑ rate of drug metabolism → ↓ drug concentration & efficacy.
- 📌 Mnemonic: Guinness, Corona, & PBRS induce Chronic Alcoholism
- Griseofulvin, Carbamazepine, Phenytoin, Barbiturates, Rifampin, St. John's Wort, Chronic alcoholism.
-
Enzyme Inhibitors: ↓ rate of drug metabolism → ↑ drug concentration & risk of toxicity.
- 📌 Mnemonic: CRACK AMIGOS
- Cimetidine/Ciprofloxacin, Ritonavir, Amiodarone, Chloramphenicol, Ketoconazole, Alcohol (acute), Macrolides, Isoniazid, Grapefruit juice, Omeprazole, Sulfonamides.
⭐ Grapefruit juice irreversibly inhibits intestinal wall CYP3A4, markedly ↑ bioavailability of drugs like statins (e.g., atorvastatin, simvastatin) and non-dihydropyridine calcium channel blockers.
High‑Yield Points - ⚡ Biggest Takeaways
- First-pass metabolism is the pre-systemic elimination of a drug, primarily by the liver and gut wall, before reaching systemic circulation.
- It significantly ↓ decreases the oral bioavailability of susceptible drugs.
- Drugs with high extraction ratios (e.g., lidocaine, nitroglycerin) have very low oral bioavailability.
- Routes like IV, sublingual, and transdermal bypass the liver's first pass.
- Liver disease like cirrhosis can reduce first-pass metabolism, increasing drug toxicity risk.
- This necessitates higher oral doses than IV doses for drugs like propranolol.
Unlock the full lesson and continue reading
Signup to continue reading this lesson and unlimited access questions, flashcards, AI notes, and more